Lucentis Ranibizumab Injection Trademark Details

Lucentis Ranibizumab Injection was registered on Tuesday, February 19, 2008 and is currently owned by Genentech, Inc. under the registration number 3386828 . This mark is alive with a status of Section 8 & 15-Accepted and Acknowledged. The last case file activity for this mark occured 10 years ago on Saturday, November 23, 2013, according to the United State Patent & Trademark Office
Word Mark Lucentis Ranibizumab Injection
Status Alive Registered 702 — Section 8 & 15-Accepted and Acknowledged

Current Owner

Genentech, Inc. of South San Francisco, CA

View all trademarks for Genentech, Inc.
Other Trademarks for Genentech, Inc.
Serial Number 78914719
Registration Number 3386828
Status Date Saturday, November 23, 2013
Filing Date Saturday, November 23, 2013
Registration Date Tuesday, February 19, 2008
Attorney Ronald E. Shapiro

Correspondent

Ronald E. Shapiro
Shapiro and Silverstein PLLC
11350 Random Hills Road, Suite 740
Fairfax VA 22030

Case File Statements

Indication of Colors Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text "Ranibizumab Injection"
Description of Mark The mark consists of the words LUCENTIS RANIBIZUMAB INJECTION and an oval inside a crescent above the word LUCENTIS.
Goods & Services Pharmaceutical Preparations for the Treatment of Angiogenesis Diseases and Disorders, and Ocular Diseases and Disorders

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Wednesday, June 28, 2006
First Use Anywhere Friday, June 30, 2006
First Use In Commerce Friday, June 30, 2006
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.